Prescribing Analysis and Cost (PACT) data are sent to all GPs to assist them in monitoring their prescribing. Although the quarterly Standard Reports contain a great deal of information it is not known how GPs make use of it. This paper reports on two linked studies which explore GPs' views on PACT Standard Reports and PACT catalogue data. In the rst study, interviews were carried out with 21 GPs in 16 practices selected according to criteria related to their prescribing budget. The interview schedule included questions on how the Standard Reports were used and the amount and ease of understanding of the information provided, and on use of PACT Catalogue data. The second study was a questionnaire survey of the 1047 practices in the West Midlands region in which GPs were asked how they used PACT data. Analysis of the interviews showed that GPs' views on the Standard Report varied widely although most found it helpful. Many GPs used the data in a limited way and only used a small part of them. Single-handed GPs and small practices were least likely to make use of PACT data and few practices analysed the data in any depth. Most respondents said that comparing their costs with health authority and national averages was useful for considering where to make changes in their prescribing. GPs indicated they would like the report to include some interpretation of the data with suggestions for changes which could be made. The regional survey con rmed that PACT Standard Reports are only used in a limited way and how they are used varies with practice size. We conclude that PACT Standard Reports were rarely used to analyse prescribing in any depth and GPs need more support in making better use of the data.
Introduction
General practice prescribing costs increased by an average of 9% per year from 1987 to 1997 (Prescription Pricing Authority 1997) and there has been increasing pressure on individual general practitioners (GPs) to control their prescribing costs. There is now new and greater formal organizational pressure from Primary Care Groups (PCGs) which, together with a new funding for-mula, were introduced in April 1999 and have a cash-limited budget. Many PCGs are now merging to form PCTs with more responsibilities and greater control of the budget. A number of external methods for cost control have been introduced including fundholding (Bradlow and Coulter, 1993) , the prescribing incentive scheme (Bateman et al., 1996) and indicative prescribing budgets (Greenhalgh, 1998; Majeed and Head, 1998) . One tool which, in theory, allows GPs to look critically at the nature and cost of their prescribing is PACT (Prescribing Analysis and Cost) data but little is known about how GPs use it.
PACT data, produced by the Prescription Pricing Authority (PPA), was introduced in 1988 and changed to its present form in 1994 (Prescription Pricing Authority, 1994) . PACT Standard Reports are sent quarterly by the PPA to individual GPs in paper format. The Standard Report provides statistics comparing the prescribing activities of the practice as a whole and some data on individual GP prescribing. The statistics are compared with the Health Authority (HA) equivalent and a national equivalent, and include the change from the previous year, thus allowing a GP to make basic performance comparisons (Bevan, 1996) . A PACT catalogue is available on request from the PPA and provides a complete breakdown of prescribing at GP or practice level down to individual drugs or BNF groups according to the level of detail requested.
A thorough analysis of PACT data, therefore, can potentially yield a great deal of useful information which could be used to monitor individual and practice prescribing patterns. However, one study found no evidence to support the view that PACT had increased awareness among GPs of the cost of their prescribing decisions (Ryan et al., 1992) . Majeed et al. (1997) have suggested that many GPs may not make much use of PACT. As the PACT Standard Report is 12 pages (including the centre page report on a special topic) and the catalogue can be very long, low usage might simply be due to time constraints or to the need for training in analysis and interpretation in order for GPs to maximize their use of the data.
No study exists of how GPs use PACT since the current format was introduced in 1994. This paper reports the results of two linked studies which asked GPs about their methods of controlling prescribing costs and included questions on their attitudes to and use of PACT data. The rst of these was a qualitative study of 16 practices selected according to criteria related to their prescribing budget. The results were used to inform the development of a questionnaire for the second study, which was a survey of all the practices in the West Midlands region.
Methods

Study 1
This was designed with a purposive sample recruited from the extremes of the selection criteria (practices with either a high-or low-budget allo-cation relative to the HA average) in order to encompass a wide range of views (Mays and Pope, 1995) . Sixteen practices were selected from within Birmingham Health Authority to include eight with a 'high' and eight with a 'low' prescribing budget allocation relative to the HA average ( Figure 1 ). Initially, two fundholding and two nonfundholding practices were selected for each over and underspending subgroup, but at the time of the interviews there were 10 fundholding and six nonfundholdin g practices due to changes in fundholding status. A total of 44 practices were approached until 16 practices had been recruited into the appropriate categories.
In-depth interviews were carried out with 21 GPs in the 16 practices between June 1997 and February 1998. One practice (P10) employed a pharmacist who was also interviewed. All the interviews were recorded and transcribed. The main analysis was carried out by authors M.J., S.G. and F.S. The transcripts were analysed by the technique of charting (Bryman and Burgess, 1994) , which involved repeatedly reading the transcripts and independently selecting and reorganizing responses according to themes. Developing themes were then discussed and further re ned in meetings of all the authors. Further details of the interviews and analysis are described elsewhere (Stevenson et al., 1999) . The semi-structured interview schedule included speci c questions on the PACT Standard Report and focused on four areas: amount of information, ease of understanding of the information provided, how it was used and how helpful it was perceived to be. The GPs were also asked about their use of PACT Catalogue data.
Study 2
The themes resulting from the interviews were used to develop a four page postal questionnaire containing both open (free text) and closed (tick box) questions on a range of issues which might have an in uence on prescribing budgets. The themes covered were: perceived in uences on practice drug spending, such as patient groups, ethnic mix, environmental factors and prevalence of chronic disease; external sources of prescribing advice and information; use of PACT data; measures taken to reduce prescribing costs; and sociodemographic data. The questionnaire included a list of 11 sections of the PACT Standard Report and respondents were asked to indicate which sec- tions they used and which they found most useful in helping them to analyse their prescribing. Respondents were also asked if they had ordered the PACT Catalogue in the last 2 years and how they had used it, and to indicate if their practice costs were above or below the HA equivalent based on their Standard Report for the quarter ending December 1997. The questionnaire was sent to the senior partner in all 1047 practices in the West Midlands Region. Two further mailings were sent to non-responders.
Responses to open questions were analysed independently by two of the researchers who selected and reorganized the responses according to themes. The data were coded and analysed by SPSS 8 for Windows. Nonparametric tests were used to analyse the data as appropriate. Statistical tests were employed for the comparison of frequencies (x 2 test), trends in proportions (x 2 for trend) and comparison of independent groups (Mann-Whitney U test). For the purposes of analysis, practices were divided into four groups according to size. Practices were de ned as small (1-2 partners), medium (3-4 partners) and large (5 or more partners).
Results
Study 1 (interviews)
The overall use of PACT Standard Reports was limited both in the amount and the depth in which they were used. The way in which PACT was used varied with practice size, with larger practices generally using it in a more systematic way. GPs in smaller practices felt that they already knew well enough their own prescribing. There was also some confusion among GPs between the quarterly Standard Reports and monthly budget statements, which are also prepared by the PPA; some GPs discussed these interchangeably which suggested a super cial use of the data rather than a detailed analysis. The main themes arising from the interviews, with examples, are summarized in Box 1.
Box 1 Summary of themes from interviews
· Theme 1 -How PACT Standard Reports are used: '. . .but for us we know what is happening more or less in a small practice. I look at it I don't analyse it.' GP8 (low, under, NFH, 1) a '[pharmacist] has them . . . and discusses them but we don't. I don't keep it or look at it regularly or check it.' GP14 (high, under, FH, 7) 'Yes, we do [a regular analysis] then we discuss it to see what is going on, if we can improve it.' GP17 (high, over, FH, 2) 'I look through it when I want to but I will not do an analysis.' GP5 (low, under, FH, 1) 'we do all read our PACT data and have made efforts, though on a kind of as and when basis rather than a formal way. . . . I don't always use the PACT stuff in any great depth because I haven't got time.' GP3 (high, over, FH, 4.5) 'we look at our gures and we do discuss things amongst ourselves but I wouldn't say we have a speci c regular meeting about it.' GP6 (high, over, FH, 3) 'The top 40 give us an indication of where to try next for a prescribing initiative . . . the rst 5 are impossible to change so you don't.' GP12 (low, over, FH, 3) 'I look at where they have broken it down systemwise sometimes because once we found so much dressings on the PACT . . . and we were wondering why this was and I managed to nd out the problem.' GP8 (low, under, NFH, 1) 'there are reductions in certain areas, the earlier ones, antibiotics which was one of the rst that we really concentrated on and a little bit in the GI section as well, the sort of shift from Losec to Zoton for example. So that is starting to show up in PACT.' GP14 (high, under, FH, 7) · Theme 2 -Ease of understanding:
'Well reasonably easy, the bit I look at, but I generally do not look through it in a great deal of depth.' GP13 (low, over, FH, 3) 'the way they present the data is very dif cult.' GP20 (high, under, NFH, 1) · Theme 3 -Perceptions of the helpfulness of PACT: 'The most important thing is the total prescribing cost . . . to see whether we are at least maintaining the level of control on expenditure . . . Everybody is having trouble but if we are having no more trouble relative to them then we are not falling behind.' GP12 (low, over, FH, 3) 'I can see if I am sticking up like the BT Tower over the rest of the district or nationally.' GP20 (high, under, NFH, 1) 'Something else that I found very good is that once or twice there has been a few blue pages included and they give a review of some particular topic and they are very good.' GP1 (low, over, NFH,  How PACT Standard Reports are used Many GPs tended to use the data in a limited way and only used a small part of them in an individualistic way. Only a few practices reported using the data in a more systematic way and carrying out a regular analysis of them. This included Practice 10 which employed a pharmacist who carried out this work. However, most GPs said they only 'look' at the data rather than analyse it and use it in a much more informal way.
None of the seven single-handed GPs and few of the small practices said they carried out a regular analysis of the Report, but the GPs in practices with two or more partners reported having some discussion of the data between the partners even if they did not carry out a formal analysis.
There was a wide range of views on the bene ts of PACT data but the majority of respondents reported using the information on the front page, which compares total spending per quarter with the HA and national equivalents and with the same quarter in the previous year. Several also used the comparisons for the individual therapeutic groups. The '20 leading cost drugs' and charts showing trends in prescribing were also cited as sections which were 'looked at'. Some practices had also used the data in a more speci c way to identify problem areas, e.g., dressings, or to monitor the effect of policy decisions and initiatives taken to reduce costs. The sections on '20 leading cost drugs' and 'top 40 BNF sections', in particular, were used to review individual drugs and for monitoring changes.
Ease of understanding of PACT Standard Reports
There was a very mixed response as to how easy the Standard Report was to understand. Although over half the GPs described the report as easy or reasonably easy to understand, this may have been partly because they only used selected sections of it and did not analyse it in any depth.
Among the GPs who said they did not nd it easy, particular dif culties were reported with the bar charts which were felt to be 'slightly confusing' and there was uncertainty whether the data referred to the practice or each partner.
Perception of the helpfulness of PACT data
The comparison of total costs with HA and national equivalents on the front page was reported to be the most helpful section as this allowed a rapid assessment of their prescribing. There was widespread feeling that a practice should aim for their costs to be near the average, as being too high or too low could draw unwanted attention to their prescribing from the HA.
Many GPs also found it helpful to see trends in their prescribing and the graphs were a useful way of showing these. Several GPs said that they found the bar charts confusing and numbers dif cult to interpret whereas the graphs made it easier to see how their prescribing was changing.
A few GPs said that they did not like PACT data or that the data's limitations themselves restricted their usefulness. GP8 suggested that each practice is different and that individuality should be taken into account. GP12 noted that there was no link between prescribing and morbidity. GP18 who had overspent and was on a 'high' budget found the data least helpful.
Amount of information in PACT Standard Report
Two-thirds of the GPs stated that the amount of information in the Standard Report was 'about right' or 'reasonable' although these included GPs who also said that they only used part of the data. The main reason for not wanting any more information was that there would be insuf cient time to read it.
The main request was for more interpretation of the data to be included and for this to be personalized; for example, suggestions for which drugs could be substituted for those highlighted as expensive, key areas for the practice to review and 'how to reduce my costs rather than saying this is what your cost is'.
PACT catalogues
Only three GPs said that they requested the PACT catalogues. A further eight GPs said that they had requested it in the past, but did not feel the need for it at present, mainly because they would not have time to analyse it. Of the 10 GPs who had not used the PACT catalogue, one said he would like to look at it and another had never heard of it.
Study 2 (questionnaire)
Response rate and responder characteristics
All 1047 practices in the West Midlands region were mailed and a completed questionnaire was returned by 452 practices (43%). The response rate from larger practices was signi cantly higher but there was little difference between those who stated that their costs were above or below their HA equivalent (Table 1) . The proportion of dispensing practices (11.3% of responding practices) was comparable to the proportion of dispensing GPs (10.8%) in the West Midlands. Fifty-ve per cent of dispensing practices stated that their prescribing costs were below their HA equivalent.
Use of PACT Standard Reports
All responders: Of all responders 7% reported not using any sections of the Standard Report to monitor their costs ( Table 2 ). The mean number of sections used was 5.4 with a median of ve. The most frequently used section was the summary information of practice prescribing costs on the front page. Almost a third of respondents did not nd any of the sections helpful. Only two sections appeared to be at all helpful for analysing prescribing costs: 20 leading cost drugs and practice prescribing costs. By fundholding status: A higher percentage of fundholders than nonfundholders used all sections but the difference was only signi cant for four sections (Table 2) , and only two sections were signi cantly more likely to be considered helpful by fundholders. Fundholders used a median of six sections compared with ve sections by nonfundholders (z = 2 2.661, P = 0.008).
By practice size: For all sections of the Standard Report, the proportion of practices using the data varied with practice size (Table 3) . Single-handed GPs used PACT data the least and larger practices were almost twice as likely to use some sections. Only two sections showed a signi cant difference between practice size in how helpful they were felt to be.
By relative costs: In only one section was there a signi cant difference in the reported use of PACT data between practices with costs above or below their HA equivalent; those below the HA equivalent were more likely to use the section showing average cost per item (P = 0.018). 
PACT catalogue
The PACT catalogue was requested by only a third of respondents within the last 2 years (Table  2) , and slightly fewer had used the information. Larger practices and fundholders were signi cantly more likely to send for and use a PACT catalogue (Table 3 ). There was no difference, however, between those practices with costs above or below their HA equivalent. Uses of the catalogue are shown in Table 4 . The catalogue was analysed by the prescribing adviser or a pharmacist in almost a third of the practices who used the data. 
Discussion
This study shows that the majority of the data in the PACT Standard Report was not used by GPs and only simple measures of prescribing were used regularly as a benchmark.
A number of issues identi ed in the qualitative study were con rmed by the survey of the whole region, for example, that small practices used PACT data differently to larger practices. Some of the single-handed practitioners stated that they knew their own prescribing and therefore had no need to analyse it. Small practices were less likely to make use of PACT, i.e., external written information supplied to them about their prescribing behaviour, and this supports other ndings from research into the behaviour of small rms (Nayak and Green eld, 1994) . This study found little difference between practices with high-or low-prescribing costs in the way they used PACT data. However, our nding that GPs with costs below the HA equivalent were more likely to use the section showing average cost per item is consistent with the nding from another study (Avery et al., 2000) that GPs in practices with either high-or low-prescribing costs have different views concerning drug substitution with comparable but cheaper drugs. GPs receive two different reports detailing their prescribing costs: the PACT Standard Report and a monthly budget statement related to their target budget, and this appears to result in con icting messages. Many GPs in the interviews reported that they read the 'practice prescribing costs' summary on page one of the Standard Report to see if they were above or below the HA average and used this as a measure of whether their costs were acceptable. This may re ect dissatisfaction with the budget allocation (Baines and Parry, 2000; Roberts, 1998) . Some GPs were not motivated to achieve their budget as they considered the budget to be inadequate and unrelated to the needs of their patients. Some expressed concern about the budget-setting process itself, suggesting that if they achieved their budget then it would be set even lower the following year, whereas aiming to be close to the HA and national averages was perceived to be a more acceptable goal. The summary of practice prescribing costs also emerged as the most frequently used section in the questionnaire. Almost a third of the GPs in the survey did not nd any sections of PACT useful, suggesting that PACT is not used to the extent it could be to improve the quality and cost of prescribing. GPs preferred a presentation which allowed them to see trends or changes at a glance, for example, comparisons with the HA and graphs. Time is a major constraint on a more detailed use of PACT. It is therefore necessary to develop new and more accessible ways of presenting prescribing data so that the effort which is involved in preparing this important information is not wasted. Interpretation of the data and communication of important ndings to GPs has been shown within the context of fundholding to be one of the fundamental roles of the practice-based pharmacist (National Prescrib-ing Centre, 1998). It is suggested that this will continue in PCGs (Audit Commission, 2000) . The study raises further issues which are relevant to the management of prescribing in PCGs. PACT is produced nationally by the PPA but suggestions from GPs for additional information were for more personalized information and interpretation. That requires knowledge of the local community and GPs' circumstances and is unlikely to be feasible for the PPA. However, this is an area which PCGs could address at a local level.
Setting appropriate prescribing budgets and helping GPs to understand how they can use available cost data better will be equally important in the PCG climate, since group dynamics within the PCGs could lead to a blame culture directed at overspenders. The continuing development and mergers of PCGs and the opportunity to change to PCT status (Audit Commission, 2000) will emphasize the need for greater understanding of the potential and utility of information systems in order to manage prescribing expenditure most effectively (Majeed and Malcolm, 1999) .
